about
Plasticity of Candida albicans BiofilmsIL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicansInnocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and diseaseRecent mouse and rat methods for the study of experimental oral candidiasisNiche-specific requirement for hyphal wall protein 1 in virulence of Candida albicansIL-1 Coordinates the Neutrophil Response to C. albicans in the Oral MucosaIn Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans BiofilmsAnimal models for candidiasisDifferent tumor necrosis factor α antagonists have different effects on host susceptibility to disseminated and oropharyngeal candidiasis in mice.Overview of vertebrate animal models of fungal infection.SR-like RNA-binding protein Slr1 affects Candida albicans filamentation and virulence.Activity of potent and selective host defense peptide mimetics in mouse models of oral candidiasisCandidalysin is a fungal peptide toxin critical for mucosal infectionHost cell invasion by medically important fungiClinical implications of oral candidiasis: host tissue damage and disseminated bacterial diseaseCX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans.Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis.C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins.In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral CandidiasisAntigen-Specific Th17 Cells Are Primed by Distinct and Complementary Dendritic Cell Subsets in Oropharyngeal CandidiasisA Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance.Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.Neutrophils Do Not Express IL-17A in the Context of Acute Oropharyngeal Candidiasis.EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infectionRole of Arf GTPases in fungal morphogenesis and virulenceCandida albicans cell shaving uncovers new proteins involved in cell wall integrity, yeast to hypha transition, stress response and host-pathogen interactionDevelopment and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.The 'obligate diploid' Candida albicans forms mating-competent haploidsA novel bioluminescence mouse model for monitoring oropharyngeal candidiasis in mice.Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis.Batf3-dependent CD103(+) dendritic cell accumulation is dispensable for mucosal and systemic antifungal host defense.Histatin 5-spermidine conjugates have enhanced fungicidal activity and efficacy as a topical therapeutic for oral candidiasis.Role of retrograde trafficking in stress response, host cell interactions, and virulence of Candida albicans.Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response.Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis.Targeting Candida albicans filamentation for antifungal drug development.Recent advances in host defense mechanisms/therapies against oral infectious diseases and consequences for systemic disease.Pathogenesis of Candida albicans biofilm.The Aryl Hydrocarbon Receptor Governs Epithelial Cell Invasion during Oropharyngeal Candidiasis.PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients.
P2860
Q26744150-521F4897-60F3-42FB-941D-98E9222729F6Q26799351-F0962A26-9AFD-4831-A1DA-8054C3F494B2Q26830891-A63C1C22-F69D-4133-B4D7-04FD3C0EC4E1Q27009285-89A8FFC5-2BE2-428B-AF8E-5312D9D6E284Q27301458-5110C369-57C0-4AB7-9A51-31F14C4F43DFQ27312015-D362C531-C35E-4AE5-B8D0-681C2B1510B9Q28550206-C9F5FE6E-E4E5-476B-86C4-79188B1CAE01Q33870482-D4A50986-6E2C-4944-99F2-3468215A0E87Q33927362-9346C215-2AA8-477D-B1D6-B19BB381C55DQ34175500-457689DF-944F-4266-8C0F-54750A00D068Q34326239-F736652F-7BB7-44CA-837D-3173FAA036FFQ34416327-A0E75F7F-4525-4F79-BD6D-2146EA8F041CQ34520268-451F854D-9F06-456F-A997-B9AAB92113E4Q34930227-82ACCB06-CA4E-4FAA-8408-F7EBBB11F872Q34955558-3D0C2C1B-22BA-4010-ACEC-21E9CADA2409Q35098244-2DCB27E2-1D83-41D8-8103-BD275F7AA022Q35301398-C4E3DFE9-3DA7-42DE-8E25-48F70E063393Q35758463-EBBE5F96-6218-4834-A437-EA9323C5965FQ35791192-EF2B391A-CBC5-443E-B4B2-DF6B51471159Q35797441-C451B065-7F35-4636-940F-F736AD5ADEA7Q35874892-E63D70A9-EE8A-4E4D-B217-F4CEED00DEA9Q36080619-9C8570DA-8F2B-4E5E-A355-D51CA730AA58Q36096377-977E04AF-9E47-4730-A2F8-38A27C31EDECQ36212929-8D2E752C-0547-44DE-A938-2B3321CA3288Q36278778-37254D1A-A654-4A52-9097-DF7FE116D2B4Q36487911-B6910F4C-66F7-44AD-9237-DD57A342654EQ36571953-2C4005B0-676C-4CFF-90C0-1D01AC62DE74Q36642581-05873372-0EDE-40B2-88B2-95711953C006Q37014780-BDB2E6EA-AC0E-4AE0-A7E0-A2730F0F0958Q37111268-800EC65F-4229-4186-A144-95F355F56005Q37268432-A0F48A48-A3CF-40F8-A856-1A14FE793F6CQ37544689-402A2349-519C-4555-B0D5-5B14C5343A62Q37545160-294FAD3E-5F2E-42A6-BA1E-E81A3951B0B8Q37641808-97231EA6-79E3-4AF1-9EB0-6169DBA2143FQ37643893-863B34FF-F300-4720-B194-4156CF08EADCQ37705311-A7B3C86F-64FF-40E7-AEF4-EC123CDB3E56Q38204891-B31478C0-508A-434F-85B6-2030BB152114Q38767464-05E26B82-A0CC-430B-B3C6-2607BC766CB8Q38888741-8C4B5736-A694-4991-BCF9-EAFC7C84F73BQ40134025-28B7CD68-DF1E-4021-A2E8-EE35EB9FAAE3
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mouse model of oropharyngeal candidiasis.
@en
type
label
Mouse model of oropharyngeal candidiasis.
@en
prefLabel
Mouse model of oropharyngeal candidiasis.
@en
P2860
P356
P1433
P1476
Mouse model of oropharyngeal candidiasis.
@en
P2093
Norma V Solis
Scott G Filler
P2860
P2888
P304
P356
10.1038/NPROT.2012.011
P577
2012-03-08T00:00:00Z